We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.03B
AUM Growth
+$28.5M
Cap. Flow
-$135K
Cap. Flow %
-0.01%
Top 10 Hldgs %
33.44%
Holding
319
New
21
Increased
83
Reduced
96
Closed
13

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$11.3M
2
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$3.26M
3
AMGN icon
Amgen
AMGN
+$2.31M
4
ABB
ABB Ltd
ABB
+$2.26M
5
BSCL
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
+$664K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$9.25M
2
QCOM icon
Qualcomm
QCOM
+$3.28M
3
JCI icon
Johnson Controls International
JCI
+$3.23M
4
AGN
Allergan plc
AGN
+$1.79M
5
DBI icon
Designer Brands
DBI
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 22.2%
2 Financials 15.74%
3 Consumer Discretionary 14.13%
4 Healthcare 11.83%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORBC
201
DELISTED
ORBCOMM, Inc.
ORBC
$347K 0.03%
47,900
+16,300
+52% +$116K
SVC
202
Service Properties Trust
SVC
$1.08B
$343K 0.03%
2,740
+400
+17% +$51.3K
QQQ icon
203
Invesco QQQ Trust
QQQ
$449B
$342K 0.03%
1,833
– –
CTO
204
CTO Realty Growth
CTO
$744M
$340K 0.03%
+20,999
New +$344K
UTF icon
205
Cohen & Steers Infrastructure Fund
UTF
$3.1B
$332K 0.03%
12,800
– –
FCT
206
First Trust Senior Floating Rate Income Fund II
FCT
$251M
$329K 0.03%
27,300
-4,600
-14% -$55.4K
ICCC icon
207
ImmuCell
ICCC
$101M
$329K 0.03%
50,670
– –
LAZ icon
208
Lazard
LAZ
$4.23B
$325K 0.03%
9,450
+617
+7% +$22.1K
GILD icon
209
Gilead Sciences
GILD
$162B
$324K 0.03%
4,800
– –
FEIM icon
210
Frequency Electronics
FEIM
$697M
$323K 0.03%
28,397
– –
PSX icon
211
Phillips 66
PSX
$83.3B
$321K 0.03%
3,436
– –
VLGEA icon
212
Village Super Market
VLGEA
$636M
$321K 0.03%
12,100
+1,700
+16% +$46.1K
MS icon
213
Morgan Stanley
MS
$337B
$320K 0.03%
7,300
– –
NTRS icon
214
Northern Trust
NTRS
$22.4B
$315K 0.03%
3,500
– –
PG icon
215
Procter & Gamble
PG
$346B
$314K 0.03%
2,865
+35
+1% +$3.73K
ABT icon
216
Abbott
ABT
$182B
$312K 0.03%
3,710
– –
AFG icon
217
American Financial Group
AFG
$12B
$307K 0.03%
3,000
– –
GENC icon
218
Gencor Industries
GENC
$218M
$307K 0.03%
23,608
– –
PED icon
219
PEDEVCO
PED
$153M
$304K 0.03%
7,305
– –
MFC icon
220
Manulife Financial
MFC
$73.2B
$300K 0.03%
16,482
– –
TIF
221
DELISTED
Tiffany & Co.
TIF
$299K 0.03%
3,190
– –
AAPL icon
222
PUT
Apple
AAPL
$4.95T
$297K 0.03%
+6,000
New +$292K
ESGV icon
223
Vanguard ESG US Stock ETF
ESGV
$13B
$297K 0.03%
5,800
– –
ADBE icon
224
Adobe
ADBE
$94.5B
$295K 0.03%
+1,000
New +$278K
ABBV icon
225
AbbVie
ABBV
$454B
$289K 0.03%
3,976
+1,051
+36% +$82.6K
7 8
9
10 11

Similar funds

SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return
AAIM
American Assets Investment Management San Diego, California $1.47B AUM 43% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return

Shufro Rose & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Shufro Rose & Co held 319 positions worth $1.03B, up 2.9% from $999M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Shufro Rose & Co's Q2 2019 filing shows 21 new, 83 increased, 96 reduced and 13 closed positions. Its largest new stake was Covetrus, Inc. Common Stock: 20,390 shares worth $499K. The largest sale was DuPont de Nemours, an estimated $9.25M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Shufro Rose & Co's largest Q2 2019 buy was Covetrus, Inc. Common Stock: 20,390 shares worth $499K.
  • Shufro Rose & Co added most to UnitedHealth in Q2 2019, an estimated $11.3M increase.
  • Shufro Rose & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $3.28M.
  • Shufro Rose & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $9.25M.
  • Shufro Rose & Co's ten largest holdings make up 33% of its $1.03B portfolio in Q2 2019.
  • Shufro Rose & Co opened 21 new positions and closed 13 in Q2 2019.
  • Shufro Rose & Co's portfolio value rose 2.9% quarter-over-quarter to $1.03B.

Based on Shufro Rose & Co's 13F filing for Q2 2019, filed 24 Jul 2019.